Page last updated: 2024-11-06

ibuterol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ibuterol is a β2-adrenergic receptor agonist. It is a chiral molecule, and the (R)-enantiomer is more potent than the (S)-enantiomer. Ibuterol is a bronchodilator and is used to treat asthma and chronic obstructive pulmonary disease (COPD). It is also used to prevent exercise-induced bronchospasm. Ibuterol is typically administered by inhalation, but it can also be given intravenously. Ibuterol is a relatively safe drug, but it can cause side effects such as headache, tremor, and tachycardia. Ibuterol is a potent bronchodilator that can be used to treat asthma and COPD. It is a relatively safe drug, but it can cause side effects. It is being studied for its potential to treat other diseases, such as cancer and Alzheimer's disease.'

ibuterol: diisobutyrate ester of terbutaline; RN given refers to parent cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68698
CHEMBL ID2104339
SCHEMBL ID118615
MeSH IDM0057475

Synonyms (18)

Synonym
kwd-2058
ibuterol
[3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate
53034-85-8
CHEMBL2104339
unii-7v12dup1ce
ibuterolum [inn-latin]
ibuterolum
7v12dup1ce ,
terbutalindiisobutyrat
einecs 258-311-4
kwd 2058
2-methylpropanoicacid 5-(2-((1,1-dimethylethyl)amino)-1-hydroxy ethyl)-1,3-phenylene ester
ibuterol [inn]
5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene diisobutyrate
SCHEMBL118615
Q27268884
DTXSID70866296
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 104.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index104.15 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index184.36 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (104.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (37.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (62.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]